Ralph Udeh is a COVID-19 researcher and a clinician with interest in the epidemiology of COVID-19, COVID-19 clinical trials, molecular virology, biostatistics, other infectious diseases and cancer. He is particularly interested in understanding the molecular underpinnings of COVID-19 and virology at large. His most recent work is focused on developing a clinical trial protocol for tasquinimod in COVID-19 [The TASQ-COVID trial]. With great enthusiasm, he looks forward to advancing his career in this field.